Trevi Therapeutics Aktie
7,42
USD
-0,13
USD
-1,72
%
7,43
USD
-0,12
USD
-1,59
%
Werbung
Trevi Therapeutics Aktie Analyse
03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung